HYDROmorphone HCl PF 10 mg/50 mL — Class I drug recall D-0633-2022
Terminated recall by STAQ Pharma, Inc., reported 2022-02-23, distributed in CO, OH, TX. Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled
| Recall number | D-0633-2022 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | STAQ Pharma, Inc., Denver, CO, United States |
| Recall initiated | 2022-02-03 |
| Classified | 2022-02-25 |
| Reported by FDA | 2022-02-23 |
| Terminated | 2022-09-16 |
| Distributed | CO, OH, TX |
| Quantity | 905 syringes |
| Reason classes | labeling |
| NDC | 73177-0104-05 |
| Lot numbers | 21104221A |
| Expiration dates | 2022-05-22 |
Product
HYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0104-05.
Reason for recall
Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0633-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.